BioHealth News Archive
TEDCO Invests in Baltimore Based NasaClip
COLUMBIA, Md. (November 27, 2023) – TEDCO, Maryland’s economic engine for technology companies, announced a recent $500,000 Social Impact Funds investment into NasaClip. “Nosebleeds…
Read More
End of Year 2023 Update: CarrTech Corp’s Notable Achievements and Future Endeavors
As the year 2023 comes to a close, CarrTech Corp has demonstrated remarkable progress and innovation in the biotechnology and medical device sectors. The…
Read More
cultivate(MD) Capital Funds LP Announces Investment into Previous BHCR Crab Trap Winner, Nanochon
GRAND RAPIDS, Mich., Nov. 27, 2023 /PRNewswire/ -- cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies, announced…
Read More
Gain Therapeutics Announces Closing of $10.1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option
BETHESDA, Md., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (“Gain” or the “Company”) (Nasdaq: GANX) today announced the closing of an underwritten…
Read More
Unveiling the Key to Healthcare Innovation Success: The NIH’s TABA Needs Assessment Report
Are you navigating the complex terrain of healthcare innovation? The National Institutes of Health (NIH) offers a powerful tool to guide your journey: the…
Read More
ChromaTan, Inc. Selected as a BLUE KNIGHT™ Company with laboratory space at JLABS @ Washington, DC
LOWER GWYNEDD, Penn.--(BUSINESS WIRE)--ChromaTan, Inc., a bioprocess development company revolutionizing the 123-year-old traditional batch biopurification process through transformational next-generation biomanufacturing solutions, announced today that…
Read More
President Biden Intends to Appoint Dr. W. Kimryn Rathmell as Director of the National Cancer Institute
Today, President Joe Biden announced his intent to appoint Dr. W. Kimryn Rathmell as the 17th Director of the National Cancer Institute (NCI), the federal…
Read More
MaxCyte Joins the Alliance for mRNA Medicines (AMM) as a Founding Member
MaxCyte continues supporting the advancement of novel therapeutics and looks to support education and advancement of mRNA medicines ROCKVILLE, Md., Nov. 16, 2023 (GLOBE…
Read More
Arcellx and Kite Announce Expansion in Strategic Partnership
-- Arcellx to receive $200M equity investment at $61.68 per share and an $85 million upfront cash payment -- -- Kite exercises option to…
Read More
BizJournals – Children’s National Hospital spinout ReveraGen BioPharma gearing up for muscular dystrophy drug launch
By Sara Gilgore - Staff Reporter November 14, 2023, 03:14pm EST Updated 18 hours ago Rockville’s ReveraGen BioPharma Inc., a 15-year-old Children’s National Hospital spinout, is…
Read More
Children’s National Hospital selected as member of ARPA-H Investor Catalyst Hub spoke network
The hospital will advocate for the unique needs of children as part of nationwide network working to accelerate transformative health solutions November 13, 2023…
Read More
Selecta Biosciences Announces Merger with Cartesian Therapeutics
WATERTOWN, Mass. and GAITHERSBURG, Md., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB) (the Company) today announced that it has merged with…
Read More
BioHealth Innovation, Inc. Welcomes Dr. Eric S. Edwards of Phlow Corporation to the Board of Directors and Appoints Donna J. Edmonds of BRAINBox Solutions, Inc. as Vice Chair
ROCKVILLE, MARYLAND, November 13, 2023 – BioHealth Innovation, Inc. (BHI), a leading organization dedicated to supporting and advancing the BioHealth industry, is pleased to…
Read More
The NHLBI is accepting applications for the I-Corps at NIH™ Program
The NHLBI is accepting applications for the I-Corps at NIH™ Program, which provides funding, mentoring, and networking opportunities to current Phase I SBIR/STTR awardees and Fast-Track awardees in the first phase of…
Read More
VLP Therapeutics group announces 3rd closing of funding to develop cancer, infectious disease vaccines; establish investigational vaccine manufacturing facility
US-based biotech company VLP Therapeutics, Inc. (VLPT) and its Tokyo-based group company VLP Therapeutics Japan, Inc. (VLPT Japan) together announced on November 8 the…
Read More